$CORZ

DUCHENE TODD M sold $226K of CORZ

DUCHENE TODD M (See remarks) sold 10,000 shares of Core Scientific, Inc./tx (CORZ) at $22.63 ($0.23M total) on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DUCHENE TODD M
Published Jul 8, 2026, 8:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 8, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CORZ
Neutral
high confidence
Mentioned
$CORZ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CORZNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and that it was executed under a pre-arranged 10b5-1 plan; the text does not include any new company fundamentals.

02

Market read

Primarily confirms insider liquidity activity; limited incremental trading edge absent other catalysts.

03

What to watch

The article provides no context on why the sale occurred, whether other insiders sold, or whether there were concurrent company disclosures; those factors would matter more than the sale size alone.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-08, reflecting a sale executed 2026-07-06.

Background

This is an SEC Form 4 insider transaction disclosure for Core Scientific, Inc.

Company-level read

Ticker impact

$CORZNeutralHigh confidence
Context

SEC Form 4 shows officer DUCHENE TODD M sold 10,000 shares of Core Scientific at $22.6254 on 2026-07-06 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a scheduled open-market sale (10b5-1) with no accompanying operational, financial, or regulatory catalyst described in the text.

Market effects

Minimal, as the disclosure is company-specific insider trading without sector-wide information.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with perceived risk, so traders may watch for follow-on insider activity or changes in guidance not mentioned here.

Key entities

  • Core Scientific, Inc.

    Subject of the Form 4 insider transaction disclosure (CORZ).

  • DUCHENE TODD M

    Officer who sold 10,000 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRWVMed

CoreWeave, AI landlord stocks sink to lowest levels in more than a year as the price of insuring CoreWeave's debt doubles

Neocloud stocks, including CoreWeave (CRWV), IREN, Core Scientific (CORZ), and Cipher Mining (CIFR), have fallen over 40% since July. CoreWeave's credit default swap costs have doubled, signaling increased default risk. Microsoft (MSFT) has gained nearly as much. Nebius (NBIS) is an exception, performing better due to lower debt. Elon Musk noted lenders are restricting funding for AI data center-dependent companies.

$BTC-USDMed

AI Pivot Fails to Slow Bitcoin Mining Competition as Hashrate Surges

Bitcoin's network hashrate hit a seven-month high of 1 zettahash per second, despite large miners shifting to AI. Mining difficulty rose 5.92% in October, with another 5.16% increase expected. Public miners' hashrate fell 23% while AI revenue rose 52% in Q2 2026, displacing about $1.5 billion in equipment. Companies like Core Scientific and IREN reduced Bitcoin production, while MARA and Riot absorbed displaced network share.

$APLDMed

Applied Digital Sinks 4% as Rotation Out of Debt-Funded AI Builders Extends; TeraWulf Dips 3%, Core Scientific Retreats 2%

Applied Digital (APLD) shares fell 4% to $19.59, extending a downturn in leveraged AI data center developers. TeraWulf (WULF) and Core Scientific (CORZ) also declined. JPMorgan cut APLD's bond rating to Neutral, citing debt concerns. APLD reported strong Q1 revenue growth but carries significant debt. Management maintains confidence in its balance sheet and funding plans.

$CORZHigh

KBW keeps Core Scientific at outperform, says AMD’s 1.9 GW reservation is overlooked

KBW reiterated its Outperform rating and $28 price target on Core Scientific (CORZ), citing overlooked 1.9 GW of AMD reservation capacity. The firm values existing leases at $15.54 per share, with a blended NOI/EV yield of 8.3%. KBW attended Core Scientific's investor day and noted AMD's option for additional capacity. CORZ closed at $15.43 on Tuesday, implying 81.5% upside to the target.